4 results match your criteria: "Private Hospital Sainte Marie[Affiliation]"
EBioMedicine
January 2020
Department of Medical Oncology, Georges François Leclerc Cancer Center - UNICANCER, 1 rue Professeur Marion, Dijon 21000, France; Platform of Transfer in Cancer Biology, Georges François Leclerc Cancer Center - UNICANCER, Dijon, France; Université Bourgogne Franche-Comté, Dijon, France; Genomic and Immunotherapy Medical Institute, Dijon, France; INSERM U1231, Dijon, France. Electronic address:
Background: Genomically-guided clinical trials are performed across different tumor types sharing genetic mutations, but trial organization remains complex. Here we address the feasibility and utility of routine somatic and constitutional exome analysis in metastatic cancer patients.
Methods: Exoma trial (NCT02840604) is a multicenter, prospective clinical trial.
J Gynecol Obstet Hum Reprod
January 2020
Private hospital Sainte Marie, 71100 Chalon sur Saone, France. Electronic address:
J Gynecol Obstet Hum Reprod
September 2018
Department of Urology, Private Hospital Sainte Marie, Ramsay General de Santé, 4 allée Saint Jean des Vignes, 71100 Chalon-sur-Saône, France.
Int J Gynaecol Obstet
June 2016
Private Hospital Sainte Marie, Chalon sur Saone, France.
Objective: To evaluate the feasibility, efficacy, complications, and outcomes of treatment of anterior or central compartment urogenital prolapse by placement of an anteroposterior 22-g/m(2) mesh with six straps through one anterior vaginal incision.
Methods: In a prospective study, patients treated for urogenital prolapse at a center in France between February 2008 and June 2011 were enrolled. Previous treatments, related interventions, intraoperative and postoperative complications, and anatomic outcomes were recorded during 3years of follow-up.